Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gott, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gott, J. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation

John Parker Gott

Piedmount Hospital, Atlanta, Georgia, gottjp{at}aol.com

Most cardiac operations involve the use of extracorporeal circulation with its attendant systemic inflammatory response syndrome. Many anti-inflammatory strategies hold promise for reducing the associated morbidity of cardiopulmonary bypass. The application of pharmacological and mechanical strategies to control this inflammatory response now has demonstrable clinical benefit. The additional costs of these successful strategies are offset by the economic savings and improved quality of care.

Perfusion, Vol. 16, No. 1 suppl, 5-9 (2001)
DOI: 10.1177/026765910101600i102
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
O. Warren, C. Alexiou, R. Massey, D. Leff, S. Purkayastha, J. Kinross, A. Darzi, and T. Athanasiou
The effects of various leukocyte filtration strategies in cardiac surgery
Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 665 - 676.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
S W Sutton, A N Patel, V A Chase, L A Schmidt, E K Hunley, L W Yancey, R F Hebeler, E H Cheung, A C Henry III, T P Meyers, et al.
Clinical benefits of continuous leukocyte filtration during cardiopulmonary bypass in patients undergoing valvular repair or replacement
Perfusion, January 1, 2005; 20(1): 21 - 29.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
P. K. Smith, S. K. Datta, L. H. Muhlbaier, G. Samsa, A. Nadel, and J. Lipscomb
Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials
Ann. Thorac. Surg., February 1, 2004; 77(2): 635 - 642.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
A. H Olivencia-Yurvati, N. Wallace, S. Ford, and R. T Mallet
Leukocyte filtration and aprotinin: synergistic anti-inflammatory protection
Perfusion, January 1, 2004; 19(1_suppl): S13 - S19.
[Abstract] [PDF]

Home page
 PerfusionHome page
G. A Ortolano, G. S Aldea, K. Lilly, P. O'Gara, J. D Alkon, F. Madera, T. Murad, C. P Altenbern, C. S Tritt, A. Capetandes, et al.
A review of leukofiltration in cardiac surgery: the time course of reperfusion injury may facilitate study design of anti-inflammatory effects
Perfusion, March 1, 2002; 17(2_suppl): 53 - 62.
[Abstract] [PDF]